Medeon Biodesign, Inc. (TPEX:6499)
97.60
+8.50 (9.54%)
May 21, 2025, 1:30 PM CST
Medeon Biodesign Revenue
Medeon Biodesign had revenue of 101.88M TWD in the quarter ending March 31, 2025, with 116.11% growth. This brings the company's revenue in the last twelve months to 347.55M, up 73.71% year-over-year. In the year 2024, Medeon Biodesign had annual revenue of 292.81M with 49.19% growth.
Revenue (ttm)
347.55M
Revenue Growth
+73.71%
P/S Ratio
25.88
Revenue / Employee
8.91M
Employees
39
Market Cap
8.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
Dec 31, 2020 | 123.06M | -330.71M | -72.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Oneness Biotech | 117.33M |
Center Laboratories | 1.63B |
Pegavision | 6.69B |